Skip to content

Clinical trials

Phase 3 Neuralgia, Postherpetic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia, Postherpetic Phase: Phase 3 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20065
20071
20082
20103
20111
20153
20171
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Depomed2
Grünenthal GmbH2
NeurogesX2
Assiut University1
Bial - Portela C S.A.1
Brainfarma Industria Química e Farmacêutica S/A1
Cephalon1
ContraVir Pharmaceuticals, Inc.1
Daiichi Sankyo Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia, Postherpetic24
Herpes Zoster7
Neuralgia4
Pain4
Back Pain3
Complex Regional Pain Syndromes3
Peripheral Nervous System Diseases3
Chronic Pain2
Neck Pain2
Osteoarthritis2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.